Understanding the CNS expression and immunologic targeting of PAD2 in neurological diseases has important mechanistic and clinical implications, as defining mechanisms that downregulate PAD2 expression or activity may hold promise for the treatment of these disorders. This evidence concerns the gene PADI2 and nervous system disorder.